New High-Capacity Cyclotron System Announced
By MedImaging International staff writers Posted on 27 Jun 2016 |
Image: The Cyclone KIUBE 18MeV cyclotron (Photo courtesy of IBA).
A new compact high-capacity cyclotron system has been launched at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI 2016) in San Diego, CA, USA.
Cyclotrons are used for the production of radionuclides for Positron Emission Tomography (PET) imaging procedures. The new cyclotron has an increased production capacity, and is more compact than previous models, with a footprint of less than 100 square meters. The system was designed for high-performance and reliability, and has a self-shielding option.
The Cyclone KIUBE 18MeV cyclotron was developed by Ion Beam Applications (IBA; Louvain-La-Neuve, Belgium), the world’s largest proton therapy and radiopharmacy solutions provider.
The production capacity of the new Cyclone KIUBE can be increased in steps to 20 curie of 18F in a two hour run. The first Cyclone KIUBE system is being installed at the University Hospital of Brussels (UZ Brussel; Brussels, Belgium).
Bruno Scutnaire, president of IBA RadioPharma Solutions, said, “It has been demonstrated that 18 MeV is the optimal particle energy for the highest production of most of PET radioisotopes. The Cyclone KIUBE is producing the widest range of PET radioisotopes and covers all the needs of PET radiopharmacies, including 68Ga liquid (IBA process patented) and also made for production of SPECT 99mTc”.
Related Links:
Ion Beam Applications
University Hospital of Brussels
Cyclotrons are used for the production of radionuclides for Positron Emission Tomography (PET) imaging procedures. The new cyclotron has an increased production capacity, and is more compact than previous models, with a footprint of less than 100 square meters. The system was designed for high-performance and reliability, and has a self-shielding option.
The Cyclone KIUBE 18MeV cyclotron was developed by Ion Beam Applications (IBA; Louvain-La-Neuve, Belgium), the world’s largest proton therapy and radiopharmacy solutions provider.
The production capacity of the new Cyclone KIUBE can be increased in steps to 20 curie of 18F in a two hour run. The first Cyclone KIUBE system is being installed at the University Hospital of Brussels (UZ Brussel; Brussels, Belgium).
Bruno Scutnaire, president of IBA RadioPharma Solutions, said, “It has been demonstrated that 18 MeV is the optimal particle energy for the highest production of most of PET radioisotopes. The Cyclone KIUBE is producing the widest range of PET radioisotopes and covers all the needs of PET radiopharmacies, including 68Ga liquid (IBA process patented) and also made for production of SPECT 99mTc”.
Related Links:
Ion Beam Applications
University Hospital of Brussels
Latest Nuclear Medicine News
- New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients
- New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment
- Low-Dose Radiation Therapy Demonstrates Potential for Treatment of Heart Failure